Publications by authors named "Andreas Lindauer"

Claim this Profile
F
From Radiocopper to Cold Copper: Mechanistic Modeling and Simulation to Define Clinical Response Criteria and Biomarkers for VTX-801 in Wilson Disease.
Andreas Lindauer, Bernard Benichou, Gloria González Aseguinolaza, Jean-Philippe Combal

CPT Pharmacometrics Syst Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of dopamine D2 receptor occupancy profiles between risperidone ISM versus oral risperidone and monthly paliperidone palmitate based on population pharmacokinetic modelling and simulations.
Eric Snoeck, Nicolas Luyckx, Andreas Lindauer, Lourdes Ochoa Díaz de Monasterioguren, Lourdes Anta

Expert Rev Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Efficacy Analysis and Dopamine D2 Receptor Occupancy in Adults with Schizophrenia after Treatment with the Monthly Intramuscular Injectable Risperidone ISM.
Andreas Lindauer, Eric Snoeck, Christian Laveille, Ignacio Ayani, Lourdes Ochoa Díaz de Monasterioguren

J Clin Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children.
Estefania Traver, Laura Rodríguez-Pascau, Uwe Meya, Guillem Pina, Silvia Pascual, Andreas Lindauer

CPT Pharmacometrics Syst Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug-Drug-Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine.
Tobias Kanacher, Andreas Lindauer, Enrica Mezzalana, Ingrid Michon, Celine Veau

Pharmaceutics· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentration-QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase-4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation.
Koen Jolling, Angela Äbelö, Nicolas Luyckx, Marie-Anna Nandeuil, Mirco Govoni, Andreas Lindauer

CPT Pharmacometrics Syst Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy.
Andreas Lindauer, Christian Laveille, Armel Stockis

Clin Pharmacokinet· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excel-Based Tool for Pharmacokinetically Guided Dose Adjustment of Paclitaxel.
Stefanie Kraff, Andreas Lindauer, Markus Joerger, Salvatore J Salamone, Ulrich Jaehde

Ther Drug Monit· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of cytotoxic drug concentrations occurring on the day of autologous stem cell rescue during a high-dose chemotherapy regimen.
Valerie Nock, Andreas Lindauer, Ulrich Jaehde, Charlotte Kloft

Int J Clin Pharmacol Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of soluble vascular endothelial growth factor receptor 3 (sVEGFR-3) in plasma as pharmacodynamic biomarker.
Friederike Kanefendt, Andreas Lindauer, Klaus Mross, Uwe Fuhr, Ulrich Jaehde

J Pharm Biomed Anal· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.
Irina Buß, Ganna V Kalayda, Andreas Lindauer, Michael R Reithofer, Mathea Sophia Galanski

J Biol Inorg Chem· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.
Paola Di Gion, Friederike Kanefendt, Andreas Lindauer, Matthias Scheffler, Oxana Doroshyenko

Clin Pharmacokinet· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy to 2nd International HIV-1 RNA WHO Standard: assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests.
Joachim Glaubitz, Dorothea Sizmann, Christian O Simon, Konstanze S Hoffmann, Daniel Drogan, Andreas Lindauer

J Clin Virol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of high-dose carboplatin in children and adults.
Andreas Lindauer, Christiane Eickhoff, Charlotte Kloft, Ulrich Jaehde

Ther Drug Monit· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study.
Frederike Lentz, Anne Drescher, Andreas Lindauer, Magdalena Henke, Ralf A Hilger

Anticancer Drugs· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects.
Andreas Lindauer, Timo Siepmann, Reinhard Oertel, Angelika Jung, Tjalf Ziemssen

Clin Pharmacokinet· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis